Pei Zhuang Selected Research

Pei Zhuang Research Topics

4	Choroidal Neovascularization 01/2016 - 01/2010
3	Neoplasms (Cancer) 04/2022 - 01/2021
3	Ocular Hypertension (Glaucoma, Suspect) 01/2022 - 01/2019
3	Glaucoma 01/2022 - 01/2019
3	Wounds and Injuries (Trauma) 01/2016 - 01/2010
2	Macular Degeneration (Age-Related Maculopathy) 03/2011 - 01/2010
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Sensorineural Hearing Loss 11/2021
1	Optic Nerve Diseases (Optic Neuropathy) 01/2020
1	Infarction (Infarctions) 03/2010
1	Body Weight (Weight, Body) 03/2010
1	Reperfusion Injury 03/2010
1	Hypoxia (Hypoxemia) 01/2010
1	Postmenopausal Osteoporosis 01/2009

3	Silicone OilsIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 04/2022 - 01/2021
2	Neuroprotective AgentsIBA 01/2021 - 01/2019
2	Oxidants (Oxidizing Agents)IBA 01/2016 - 01/2010
2	flavoneIBA 01/2010 - 01/2010
1	CamptothecinIBA 04/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2022
1	Peptides (Polypeptides)IBA 04/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Carisoprodol (Soma)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	SynucleinsIBA 01/2020
1	sodium iodateIBA 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2016
1	Keratin-17 (Keratin 17)IBA 01/2016
1	Retinal Pigments (Pigments, Visual)IBA 03/2011
1	AntioxidantsIBA 03/2011
1	QuercetinIBA 03/2011
1	Guanabenz (BR 750)FDA Link 01/2011
1	Antihypertensive Agents (Antihypertensives)IBA 01/2011
1	Nitric Oxide DonorsIBA 03/2010
1	(2-(1-diethylaminoacetoxy)pentyl)benzoic acid (2- methoxy- 4- (2- (4- nitrooxybutoxycarbonyl)vinyl))phenyl esterIBA 03/2010
1	salicylhydroxamic acid (SHAM)IBA 03/2010
1	Thymidine Monophosphate (TMP)IBA 01/2010
1	Type 1 Angiotensin ReceptorIBA 01/2009
1	Telmisartan (Micardis)FDA Link 01/2009
1	Valsartan (Vals)FDA Link 01/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2009

2	Lasers (Laser) 01/2016 - 01/2011
1	Drug Therapy (Chemotherapy) 04/2022
1	Immunotherapy 01/2022
1	Operative Surgical Procedures 11/2021
1	Vitreoretinal Surgery 01/2019